News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Reid Laurence
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/17/2023 |
4
| Reid Laurence (See Remarks) has filed a Form 4 on Decibel Therapeutics, Inc.|
Txns:
| Granted 195,000 shares
@ $0
Granted 72,000 options to buy
@ $3.73, valued at
$268.6k
|
|
| 02/28/2022 |
4
| Reid Laurence (See Remarks) has filed a Form 4 on Decibel Therapeutics, Inc.|
Txns:
| Granted 187,500 options to buy
@ $3.5, valued at
$656.3k
|
|
| 09/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/05/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/16/2014 |
4
| Reid Laurence (SVP, Chief Business Officer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 6,667 options to buy
@ $63, valued at
$420k
|
|
| 11/19/2014 |
4
| Reid Laurence (SVP, Chief Business Officer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Sold 5,413 shares
@ $90.3032, valued at
$488.8k
Sold 4,485 shares
@ $91.0805, valued at
$408.5k
Sold 102 shares
@ $91.7886, valued at
$9.4k
Exercised 2,500 options to buy
@ $7.1, valued at
$17.8k
Exercised 3,861 options to buy
@ $9.14, valued at
$35.3k
Exercised 3,639 options to buy
@ $15.99, valued at
$58.2k
|
|
| 08/20/2014 |
4
| Reid Laurence (SVP, Chief Business Officer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Sold 6,500 shares
@ $66.8322, valued at
$434.4k
Sold 7,000 shares
@ $67.8029, valued at
$474.6k
Exercised 2,500 options to buy
@ $7.1, valued at
$17.8k
Exercised 11,000 options to buy
@ $9.14, valued at
$100.5k
|
|
| 05/21/2014 |
4
| Reid Laurence (SVP, Chief Business Officer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Sold 2,600 shares
@ $57.067, valued at
$148.4k
Sold 10,900 shares
@ $58.0101, valued at
$632.3k
Exercised 2,500 options to buy
@ $7.1, valued at
$17.8k
Exercised 11,000 options to buy
@ $9.14, valued at
$100.5k
|
|
| 02/20/2014 |
4
| Reid Laurence (SVP, Chief Business Officer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Sold 3,079 shares
@ $78.62, valued at
$242.1k
Sold 11,465 shares
@ $80.0235, valued at
$917.5k
Sold 5,456 shares
@ $80.8505, valued at
$441.1k
Sold 400 shares
@ $81.4475, valued at
$32.6k
Exercised 10,000 options to buy
@ $7.1, valued at
$71k
Exercised 3,500 options to buy
@ $15.99, valued at
$56k
|
|
| 01/27/2014 |
4
| Reid Laurence (SVP, Chief Business Officer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 3,698 shares
@ $89.49, valued at
$330.9k
|
|
| 01/02/2014 |
4
| Reid Laurence (SVP, Chief Business Officer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 930 shares
@ $64.51, valued at
$60k
Exercised 3,752 options to buy
@ $15.99, valued at
$60k
|
|
| 12/18/2013 |
4
| Reid Laurence (SVP, Chief Business Officer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 20,000 options to buy
@ $63, valued at
$1.3M
|
|
| 11/15/2013 |
4
| Reid Laurence (SVP, Chief Business Officer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Sold 13,500 shares
@ $53.3557, valued at
$720.3k
Exercised 13,500 options to buy
@ $15.99, valued at
$215.9k
|
|
| 05/30/2013 |
4
| Reid Laurence (SVP and Chief Business Officer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Sold 5,000 shares
@ $30, valued at
$150k
Exercised 5,000 options to buy
@ $7.1, valued at
$35.5k
|
|
| 02/12/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/21/2012 |
4
| Reid Laurence (SVP, Chief Business Officer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 40,000 options to buy
@ $18.66, valued at
$746.4k
|
|
| 01/25/2012 |
4
| Reid Laurence (SVP, Chief Business Officer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 10,751 shares
@ $0 |
|
| 12/10/2010 |
4
| Reid Laurence (SVP, Chief Business Officer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 27,589 options to buy
@ $9.14, valued at
$252.2k
|
|
| 06/15/2010 |
4/A
| Form 4 - Statement of changes in beneficial ownership of securities [amend] |
| 06/15/2010 |
3/A
| Form 3 - Initial statement of beneficial ownership of securities [amend] |
| 06/03/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/03/2010 |
3
| Reid Laurence (SVP, Chief Business Officer) has filed a Form 3 on ALNYLAM PHARMACEUTICALS, INC. |
|
|